SB70-AA3,81,8 6(3) Symposia. The department may hold symposia every 2 years for recipients
7of grants under the grant program to present findings of research supported by the
8grants.

SB70-AA3,81,12 9(4) Grant reports. By January 15 of each year, the department shall submit
10an annual report to the appropriate standing committees of the legislature under s.
1113.172 (3) that identifies the recipients of grants under the grant program and the
12purposes for which the grants were used.

SB70-AA3,81,13 13(5) Council. (a) The council shall do all of the following:

SB70-AA3,81,1514 1. Develop criteria for the department to evaluate and award grants under the
15grant program.

SB70-AA3,81,1716 2. Review and make recommendations to the department on applications
17submitted under the grant program.

SB70-AA3,81,1818 3. Perform other duties specified by the department.

SB70-AA3,81,2219 (b) Each member of the council shall disclose in a written statement any
20financial interest in any organization that the council recommends to receive a grant
21under the grant program. The council shall include the written statements with its
22recommendations to the department on grant applications.

SB70-AA3,82,3

1(1) Spinal cord injury council; initial appointments. Notwithstanding the
2length of terms specified for the members of the spinal cord injury council under s.
315.197 (20) (a) (intro.), initial appointments to the council shall be made as follows:

SB70-AA3,82,64 (a) The members appointed under s. 15.197 (20) (a) 1., 3., 5., and 7., or in lieu
5of those members under s. 15.197 (20) (b), shall be appointed for terms expiring on
6July 1, 2025.

SB70-AA3,82,97 (b) The members appointed under s. 15.197 (20) (a) 2., 4., 6., and 8., or in lieu
8of those members under s. 15.197 (20) (b), shall be appointed for terms expiring on
9July 1, 2026.”.

SB70-AA3,82,11 11“ Section 78. 15.07 (3) (bm) 7. of the statutes is created to read:

SB70-AA3,82,1312 15.07 (3) (bm) 7. The prescription drug affordability review board shall meet
13at least 4 times each year.

SB70-AA3,82,17 1515.735 Same; attached board. (1) There is created a prescription drug
16affordability review board attached to the office of the commissioner of insurance
17under s. 15.03. The board shall consist of the following members:

SB70-AA3,82,1818 (a) The commissioner of insurance or his or her designee.

SB70-AA3,82,2219 (b) Two members appointed for 4-year terms who represent the
20pharmaceutical drug industry, including pharmaceutical drug manufacturers and
21wholesalers. At least one of the members appointed under this paragraph shall be
22a licensed pharmacist.

SB70-AA3,82,2423 (c) Two members appointed for 4-year terms who represent the health
24insurance industry, including insurers and pharmacy benefit managers.

SB70-AA3,83,3

1(d) Two members appointed for 4-year terms who represent the health care
2industry, including hospitals, physicians, pharmacies, and pharmacists. At least one
3of the members appointed under this paragraph shall be a licensed practitioner.

SB70-AA3,83,54 (e) Two members appointed for 4-year terms who represent the interests of the
5public.

SB70-AA3,83,8 6(2) A member appointed under sub. (1), except for a member appointed under
7sub. (1) (b), may not be an employee of, a board member of, or a consultant to a drug
8manufacturer or trade association for drug manufacturers.

SB70-AA3,83,13 9(3) Any conflict of interest, including any financial or personal association, that
10has the potential to bias or has the appearance of biasing an individual's decision in
11matters related to the board or the conduct of the board's activities shall be
12considered and disclosed when appointing that individual to the board under sub.
13(1).

SB70-AA3,80 14Section 80. Subchapter VI (title) of chapter 601 [precedes 601.78] of the
15statutes is created to read: